Medium NAPLEX Relative Risk Practice Questions

Mastering biostatistics is an essential component of NAPLEX Prep, as these concepts allow pharmacists to critically evaluate clinical literature and make evidence-based recommendations. Among the most frequently tested metrics is Relative Risk (RR), a measure of association that compares the probability of an event occurring in an exposed group versus a non-exposed group. This guide provides a comprehensive overview and medium-difficulty practice questions to ensure you are ready for exam day.

Concept Explanation

Relative Risk (RR) is the ratio of the probability of an outcome occurring in an exposed group to the probability of the outcome occurring in an unexposed group. It is a fundamental calculation used in prospective studies, such as randomized controlled trials (RCTs) and cohort studies, to quantify the strength of the association between a treatment or risk factor and a specific clinical outcome. To calculate Relative Risk, you must first determine the incidence (risk) in each group.

The formula for Relative Risk is:

$$RR = \ \frac{\ \text{Risk in Treatment Group}}{\ \text{Risk in Control Group}}$$

Where risk is calculated as:

$$\ \text{Risk} = \ \frac{\ \text{Number of subjects with the event}}{\ \text{Total number of subjects in that group}}$$

Interpreting the result is straightforward but critical for clinical decision-making:

• RR = 1: No difference in risk between the two groups.
• RR > 1: Higher risk of the outcome in the treatment group (the treatment may be harmful).
• RR < 1: Lower risk of the outcome in the treatment group (the treatment is protective).

For example, if the RR is 0.75, the treatment group is 75% as likely to experience the event as the control group, representing a 25% relative risk reduction (RRR). For more complex clinical scenarios, you may also want to review Medium NAPLEX Anticoagulation Practice Questions to see how risk is applied in medication safety.

Solved Examples

Example 1: In a study of 500 patients taking a new antihypertensive (Group A) and 500 patients taking a placebo (Group B), 20 patients in Group A and 40 patients in Group B experienced a stroke. Calculate the Relative Risk.

1. Calculate risk in Group A: $\ \frac{20}{500} = 0.04$
2. Calculate risk in Group B: $\ \frac{40}{500} = 0.08$
3. Calculate RR: $\ \frac{0.04}{0.08} = 0.5$
4. Interpretation: Patients in Group A have 0.5 times (or 50%) the risk of stroke compared to Group B.

Example 2: A cohort study followed 1,000 smokers and 1,000 non-smokers for 10 years. 150 smokers developed COPD, while 30 non-smokers developed COPD. Calculate the RR of developing COPD for smokers.

1. Risk in smokers: $\ \frac{150}{1000} = 0.15$
2. Risk in non-smokers: $\ \frac{30}{1000} = 0.03$
3. RR: $\ \frac{0.15}{0.03} = 5.0$
4. Interpretation: Smokers are 5 times more likely to develop COPD than non-smokers. You can find more respiratory-related calculations in our Medium NAPLEX COPD Practice Questions.

Example 3: In an oncology trial, 200 patients received Drug X and 200 received standard care. 10 patients on Drug X experienced severe nausea, compared to 5 patients on standard care. What is the RR of nausea with Drug X?

1. Risk in Drug X: $\ \frac{10}{200} = 0.05$
2. Risk in Standard Care: $\ \frac{5}{200} = 0.025$
3. RR: $\ \frac{0.05}{0.025} = 2.0$
4. Interpretation: Patients on Drug X have twice the risk of nausea. For more oncology-specific data, visit Medium NAPLEX Oncology Therapeutics Practice Questions.

Practice Questions

1. A clinical trial evaluates a new SGLT2 inhibitor for heart failure. In the treatment group (n=1200), 60 patients were hospitalized. In the placebo group (n=1200), 90 patients were hospitalized. Calculate the Relative Risk (RR).

2. A pharmacist is reviewing a study on a new vaccine. Out of 5,000 vaccinated individuals, 5 contracted the virus. Out of 5,000 unvaccinated individuals, 50 contracted the virus. What is the RR? Round to two decimal places.

3. Researchers are investigating the risk of AKI with a new antibiotic. 40 out of 800 patients in the antibiotic group developed AKI, compared to 20 out of 1000 in the control group. Calculate the RR.

4. In a study comparing two anticoagulants for DVT prevention, 15 out of 600 patients in the Apixaban group experienced bleeding, while 30 out of 600 in the Enoxaparin group experienced bleeding. What is the RR of bleeding for Apixaban compared to Enoxaparin?

5. A study on a new antidepressant involves 400 patients in the drug group and 400 in the placebo group. 80 patients in the drug group achieved remission, compared to 40 in the placebo group. Calculate the RR of achieving remission.

6. Investigating a side effect: 12 out of 300 patients on Drug Y developed a rash, while 4 out of 400 on Drug Z developed a rash. What is the RR of developing a rash on Drug Y compared to Drug Z?

7. A trial for a new lipid-lowering agent showed that 45 out of 1,500 patients had a cardiovascular event, while 75 out of 1,500 in the placebo group had an event. Calculate the RR.

8. In a 5-year study, 120 out of 2,000 patients with high sodium intake developed hypertension, while 60 out of 3,000 patients with low sodium intake developed hypertension. Calculate the RR of hypertension for high sodium intake.

9. A study evaluates the risk of GI bleed with NSAID use. In the NSAID group (n=500), 10 bleeds occurred. In the control group (n=1000), 5 bleeds occurred. Calculate the RR.

10. A new treatment for diabetic neuropathy was tested. 100 out of 500 patients reported improved pain scores, compared to 50 out of 500 in the placebo group. Calculate the RR of improvement.

Answers & Explanations

1. Answer: 0.67
Risk (Treatment) = $60 / 1200 = 0.05$
Risk (Placebo) = $90 / 1200 = 0.075$
RR = $0.05 / 0.075 = 0.666...$ rounded to 0.67.

2. Answer: 0.10
Risk (Vaccine) = $5 / 5000 = 0.001$
Risk (Unvaccinated) = $50 / 5000 = 0.01$
RR = $0.001 / 0.01 = 0.1$.

3. Answer: 2.5
Risk (Antibiotic) = $40 / 800 = 0.05$
Risk (Control) = $20 / 1000 = 0.02$
RR = $0.05 / 0.02 = 2.5$.

4. Answer: 0.5
Risk (Apixaban) = $15 / 600 = 0.025$
Risk (Enoxaparin) = $30 / 600 = 0.05$
RR = $0.025 / 0.05 = 0.5$.

5. Answer: 2.0
Risk (Drug) = $80 / 400 = 0.2$
Risk (Placebo) = $40 / 400 = 0.1$
RR = $0.2 / 0.1 = 2.0$.

6. Answer: 4.0
Risk (Drug Y) = $12 / 300 = 0.04$
Risk (Drug Z) = $4 / 400 = 0.01$
RR = $0.04 / 0.01 = 4.0$.

7. Answer: 0.6
Risk (Agent) = $45 / 1500 = 0.03$
Risk (Placebo) = $75 / 1500 = 0.05$
RR = $0.03 / 0.05 = 0.6$.

8. Answer: 3.0
Risk (High Sodium) = $120 / 2000 = 0.06$
Risk (Low Sodium) = $60 / 3000 = 0.02$
RR = $0.06 / 0.02 = 3.0$.

9. Answer: 4.0
Risk (NSAID) = $10 / 500 = 0.02$
Risk (Control) = $5 / 1000 = 0.005$
RR = $0.02 / 0.005 = 4.0$.

10. Answer: 2.0
Risk (Treatment) = $100 / 500 = 0.2$
Risk (Placebo) = $50 / 500 = 0.1$
RR = $0.2 / 0.1 = 2.0$.

To further test your knowledge on specific therapeutic areas, try our Retrieval Challenge for daily biostatistics review.

1. If a study reports a Relative Risk (RR) of 0.82 for a primary endpoint, how should the pharmacist interpret this finding?

• AThe treatment increases the risk by 18%
• BThe treatment reduces the risk by 82%
• CThe treatment reduces the risk by 18%
• DThe treatment has no effect on the risk

Frequently Asked Questions

What is the difference between Relative Risk and Odds Ratio?

Relative Risk compares the probability of an event occurring in two groups, whereas the Odds Ratio (OR) compares the odds of an event occurring. While RR is preferred for prospective trials and cohort studies, OR is typically used in case-control studies where the total population at risk is unknown.

Can Relative Risk be used in Case-Control studies?

No, Relative Risk cannot be directly calculated in case-control studies because these studies start with diseased individuals and look backward, making it impossible to determine the true incidence or "risk" in the population. The Odds Ratio is used as an estimate of RR in these instances.

How do you calculate Relative Risk Reduction (RRR) from RR?

Relative Risk Reduction is calculated using the formula $RRR = 1 - RR$. For example, if the RR is 0.70, the RRR is 0.30, or 30%, indicating the treatment reduced the risk of the outcome by 30% relative to the control group.

Why is Relative Risk important in the NAPLEX?

The NAPLEX emphasizes the ability to interpret clinical trials to determine if a drug is safe and effective. Understanding RR allows you to distinguish between clinical significance and statistical significance when evaluating drug approval data.

What does a Relative Risk greater than 1 signify?

An RR greater than 1 indicates that the risk of the outcome (often a side effect or disease) is higher in the exposed or treatment group than in the control group. This suggests a positive association between the exposure and the outcome, which may imply harm depending on the context.